Cargando…
Cell factories for insulin production
The rapid increase in the number of diabetic patients globally and exploration of alternate insulin delivery methods such as inhalation or oral route that rely on higher doses, is bound to escalate the demand for recombinant insulin in near future. Current manufacturing technologies would be unable...
Autores principales: | Baeshen, Nabih A, Baeshen, Mohammed N, Sheikh, Abdullah, Bora, Roop S, Ahmed, Mohamed Morsi M, Ramadan, Hassan A I, Saini, Kulvinder Singh, Redwan, Elrashdy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203937/ https://www.ncbi.nlm.nih.gov/pubmed/25270715 http://dx.doi.org/10.1186/s12934-014-0141-0 |
Ejemplares similares
-
Expression and Purification of C-Peptide Containing Insulin Using Pichia pastoris Expression System
por: Baeshen, Mohammed N., et al.
Publicado: (2016) -
GC-MS Analysis of Bioactive Compounds Extracted from Plant Rhazya stricta Using Various Solvents
por: Baeshen, Nabih A., et al.
Publicado: (2023) -
In silico screening of some compounds derived from the desert medicinal plant Rhazya stricta for the potential treatment of COVID-19
por: Baeshen, Nabih A., et al.
Publicado: (2022) -
A Review of Rhazya stricta Decne Phytochemistry, Bioactivities, Pharmacological Activities, Toxicity, and Folkloric Medicinal Uses
por: Albeshri, Abdulaziz, et al.
Publicado: (2021) -
Evaluation of cytotoxicity and antiviral activity of Rhazya stricta Decne leaves extract against influenza A/PR/8/34 (H1N1)
por: Albeshri, Abdulaziz, et al.
Publicado: (2022)